Home4582 • TYO
add
Symbio Pharmaceuticals Ltd
Previous close
¥159.00
Day range
¥157.00 - ¥161.00
Year range
¥126.00 - ¥475.00
Market cap
7.81B JPY
Avg Volume
406.69K
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 264.00M | -55.78% |
Operating expense | 1.37B | 7.36% |
Net income | -1.32B | -70.01% |
Net profit margin | -500.38 | -284.46% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -0.84% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.61B | -44.78% |
Total assets | 4.67B | -39.52% |
Total liabilities | 1.27B | 76.63% |
Total equity | 3.40B | — |
Shares outstanding | 47.27M | — |
Price to book | 2.21 | — |
Return on assets | -60.66% | — |
Return on capital | -70.49% | — |
Cash Flow
Net change in cash
| (JPY) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.32B | -70.01% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Mar 25, 2005
Headquarters
Website
Employees
108
